Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions

Blood

Volumn 113, Issue 5, 2009, Pages 1016-1026

  Cochrane, Shawn W ^a   Zhao, Ying ^a   Welner, Robert S ^a   Sun, Xiao Hong ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; E PROTEIN; GREEN FLUORESCENT PROTEIN; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E47; UNCLASSIFIED DRUG; IDB1 PROTEIN, MOUSE; T CELL FACTOR 3; T CELL FACTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; GENETIC TRANSCRIPTION; GRANULOCYTE; LYMPHOID CELL; MACROPHAGE; MOUSE; MULTIPOTENT STEM CELL; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; COLONY FORMING UNIT GM; CYTOLOGY; GENETICS; LYMPHOPOIESIS; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; LYMPHOPOIESIS; MICE; MICE, TRANSGENIC; MULTIPOTENT STEM CELLS; MYELOPOIESIS; TCF TRANSCRIPTION FACTORS;

EID: 60849083235     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-06-164996     Document Type: Article

References (50)

1. Buza-Vidas N, Luc S, Jacobsen SE. Delineation of the earliest lineage commitment steps of haematopoietic stem cells: new developments, controversies and major challenges. Curr Opin Hematol. 2007;14:315-321.
2. Kondo M, Wagers AJ, Manz MG, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003;21:759-806.
3. Welner RS, Pelayo R, Kincade PW. Evolving views on the genealogy of B cells. Nat Rev Immunol. 2008;8:95-106.
4. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404: 193-197.
5. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91:661-672.
6. Adolfsson J, Mansson R, Buza-Vidas N, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential: a revised road map for adult blood lineage commitment. Cell. 2005;121:295-306.
7. Igarashi H, Gregory SC, Yokota T, Sakaguchi N, Kincade PW. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity. 2002;17:117-130.
8. Lai AY, Kondo M. Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med. 2006;203:1867-1873.
9. Mansson R, Hultquist A, Luc S, et al. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity. 2007;26:407-419.
10. Wang JH, Nichogiannopoulou A, Wu L, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 1996;5:537-549.
11. Chen X, Liu W, Ambrosino C, et al. Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBPbeta. Blood. 1997;90:156-164.
12. Zhang DE, Zhang P, Wang ND, et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A. 1997;94:569-574.
13. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 2000;288:1439-1441.
14. DeKoter RP, Lee HJ, Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity. 2002;16:297-309.
15. Passegue E, Wagner EF, Weissman IL. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell. 2004; 119:431-443.
16. Perrotti D, Cesi V, Trotta R, et al. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet. 2002;30:48-58.
17. Engel I, Murre C. The function of E-and Id proteins in lymphocyte development. Nat Rev Immunol. 2001;1:193-199.
18. Sun XH. Multitasking of helix-loop-helix proteins in lymphopoiesis. Adv Immunol. 2004;84:43-77.
19. Greenbaum S, Zhuang Y. Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system. Proc Natl Acad Sci U S A. 2002;99:15030-15035.
20. Schwartz R, Engel I, Fallahi-Sichani M, Petrie HT, Murre C. Gene expression patterns define novel roles for E47 in cell cycle progression, cytokinemediated signaling, and T lineage development. Proc Natl Acad Sci U S A. 2006;103:9976-9981.
21. Bain G, Robanus Maandag EC, Izon DJ, et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell. 1994;79:885-892.
22. Zhuang Y, Soriano P, Weintraub H. The helixloop-helix gene E2A is required for B cell differentiation. Cell. 1994;79:875-884.
23. Sun X-H, Copeland NG, Jenkins NA, Baltimore D. Id proteins, Id1 and Id2, selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol. 1991;11:5603-5611.
24. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. he protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990;61:49-59.
25. Sun X-H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell. 1994;79: 893-900.
26. Ohtani N, Zebedee Z, Huot TJ, et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001;409:1067-1070.
27. Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ. Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system. Blood. 1997;89:3155-3165.
28. Leeanansaksiri W, Wang H, Gooya JM, et al. IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development. J Immunol. 2005;174:7014-7021.
29. Xu M, Nie L, Kim SH, Sun XH. STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO J. 2003; 22:893-904.
30. Yan W, Young AZ, Soares VC, et al. High incidence of T-cell tumors in E2A-null mice and E2A/ Id1 double-knockout mice. Mol Cell Biol. 1997;17: 7317-7327.
31. Perry SS, Zhao Y, Nie L, et al. Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance. Blood. 2007;110:2351-2360.
32. Shapiro-Shelef M, Lin KI, Savitsky D, Liao J, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med. 2005;202:1471-1476.
33. Srinivas S, Watanabe T, Lin CS, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001;1:4.
34. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999;21: 70-71.
35. Mui AL, Wakao H, Harada N, O'Farrell AM, Miyajima A. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J Leukoc Biol. 1995;57:799-803.
36. Lyden D, Young AZ, Zagzag D, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 1999;401:670-677.
37. Park ST, Sun XH. The Ta11 oncoprotein inhibits E47-mediated transcription: mechanism of inhibition. J Biol Chem. 1998;273:7030-7037.
38. Park ST, Nolan GP, Sun X-H. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J Exp Med. 1999;189:501-508.
39. Prabhu S, Ignatova A, Park ST, Sun X-H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and ID proteins. Mol Cell Biol. 1997;17:5888-5896.
40. Greenbaum S, Lazorchak AS, Zhuang Y. Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes. J Biol Chem. 2004;279:45028-45035.
41. Choi JK, Shen CP, Radomska HS, Eckhardt LA, Kadesch T. E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J. 1996;15:5014-5021.
42. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med. 1991;173:1213-1225.
43. Jankovic V, Ciarrocchi A, Boccuni P, et al. Id1 restrains myeloid commitment, maintaining the selfrenewal capacity of hematopoietic stem cells. Proc Natl Acad Sci U S A. 2007;104:1260-1265.
44. Cooper CL, Newburger PE. Differential expression of Id genes in multipotent myeloid progenitor cells: Id-1 is induced by early-and late-acting cytokines while Id-2 is selectively induced by cytokines that drive terminal granulocytic differentiation. J Cell Biochem. 1998;71:277-285.
45. Kunisato A, Chiba S, Saito T, et al. Stem cell leukemia protein directs hematopoietic stem cell fate. Blood. 2004;103:3336-3341.
46. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/ inactivation in the mouse. Dev Biol. 2002; 244:305-318.
47. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol. 2006;18:39-48.
48. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 2002;99:111-120.
49. Mathas S, Janz M, Hummel F, et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol. 2006;7:207-215.
50. Bhalla S, Spaulding C, Brumbaugh RL, et al. Differential roles for the E2A activation domains in B lymphocytes and macrophages. J Immunol. 2008;180:1694-1703.